Callahan Advisors’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.82M | Hold |
23,402
| – | – | 0.23% | 79 |
|
|
2025
Q4 | $2.46M | Sell |
23,402
-515
| -2% | -$48.3K | 0.2% | 84 |
|
|
2025
Q3 | $2.01M | Sell |
23,917
-2,173
| -8% | -$179K | 0.17% | 90 |
|
|
2025
Q2 | $2.07M | Sell |
26,090
-648
| -2% | -$51.5K | 0.19% | 89 |
|
|
2025
Q1 | $2.4M | Sell |
26,738
-898
| -3% | -$83.8K | 0.23% | 84 |
|
|
2024
Q4 | $2.75M | Sell |
27,636
-2,449
| -8% | -$252K | 0.26% | 75 |
|
|
2024
Q3 | $3.42M | Sell |
30,085
-93
| -0.3% | -$11K | 0.33% | 69 |
|
|
2024
Q2 | $3.74M | Sell |
30,178
-410
| -1% | -$52.8K | 0.39% | 61 |
|
|
2024
Q1 | $4.04M | Buy |
30,588
+7
| +0% | +$863 | 0.42% | 62 |
|
|
2023
Q4 | $3.33M | Buy |
30,581
+8
| +0% | +$830 | 0.39% | 62 |
|
|
2023
Q3 | $3.15M | Buy |
30,573
+1,577
| +5% | +$170K | 0.4% | 60 |
|
|
2023
Q2 | $3.35M | Sell |
28,996
-328
| -1% | -$37.2K | 0.41% | 62 |
|
|
2023
Q1 | $3.12M | Buy |
29,324
+8
| +0% | +$864 | 0.4% | 63 |
|
|
2022
Q4 | $3.25M | Buy |
29,316
+9
| +0% | +$920 | 0.45% | 58 |
|
|
2022
Q3 | $2.52M | Sell |
29,307
-2
| -0% | -$179 | 0.36% | 64 |
|
|
2022
Q2 | $2.67M | Sell |
29,309
-11
| -0% | -$975 | 0.36% | 67 |
|
|
2022
Q1 | $2.41M | Buy |
29,320
+3,872
| +15% | +$305K | 0.27% | 81 |
|
|
2021
Q4 | $1.95M | Buy |
25,448
+2,009
| +9% | +$160K | 0.22% | 90 |
|
|
2021
Q3 | $1.76M | Buy |
23,439
+17,931
| +326% | +$1.36M | 0.22% | 90 |
|
|
2021
Q2 | $428K | Buy |
5,508
+1,679
| +44% | +$125K | 0.05% | 120 |
|
|
2021
Q1 | $282K | Buy |
3,829
+9
| +0.2% | +$664 | 0.04% | 125 |
|
|
2020
Q4 | $298K | Sell |
3,820
-123
| -3% | -$9.41K | 0.04% | 125 |
|
|
2020
Q3 | $312K | Buy |
3,943
+324
| +9% | +$25.4K | 0.05% | 114 |
|
|
2020
Q2 | $267K | Sell |
3,619
-198
| -5% | -$14.9K | 0.05% | 116 |
|
|
2020
Q1 | $280K | Buy |
3,817
+24
| +0.6% | +$1.89K | 0.06% | 108 |
|
|
2019
Q4 | $329K | Buy |
3,793
+26
| +0.7% | +$2.14K | 0.05% | 112 |
|
|
2019
Q3 | $303K | Buy |
3,767
+8
| +0.2% | +$641 | 0.05% | 117 |
|
|
2019
Q2 | $301K | Buy |
3,759
+7
| +0.2% | +$536 | 0.05% | 117 |
|
|
2019
Q1 | $298K | Buy |
3,752
+883
| +31% | +$66K | 0.06% | 116 |
|
|
2018
Q4 | $209K | Buy |
+2,869
| New | +$203K | 0.04% | 126 |
|
|
2017
Q4 | – | Sell |
-3,802
| Closed | -$232K | – | 129 |
|
|
2017
Q3 | $232K | Buy |
3,802
+399
| +12% | +$24.2K | 0.05% | 112 |
|
|
2017
Q2 | $208K | Buy |
+3,403
| New | +$207K | 0.05% | 114 |
|
Other funds holding MRK
VCM
VPM
Callahan Advisors's MRK Position: Q1 2026 in Review
Callahan Advisors held its Merck (MRK) position steady in Q1 2026 at 23,402 shares worth $2.82M. The position accounts for 0.23% of the portfolio, ranked #79.
Callahan Advisors first reported a position in MRK in Q2 2017 and has held it in 32 quarters since. The position peaked at $4.04M in Q1 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Callahan Advisors held 23,402 shares of Merck worth $2.82M as of Q1 2026.
- Callahan Advisors left its Merck share count unchanged in Q1 2026.
- Merck made up 0.23% of Callahan Advisors's portfolio in Q1 2026, its #79 holding.
- Callahan Advisors first reported a position in Merck in Q2 2017 and has held it in 32 quarters since.
- Callahan Advisors's Merck position peaked at $4.04M in Q1 2024.
- 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Callahan Advisors's 13F filing for Q1 2026, filed 12 May 2026.